Patient clinical characteristics
Patient ID no. . | Diagnosis . | CrCl, mL/min . | Epo, mU/mL at V2, t0 . | Ret, %, at V2, t0 . | Hb, g/dL at V2, t0 . | Weight, kg . | Age, y . | Gender, F/M . |
|---|---|---|---|---|---|---|---|---|
| H001 | PCKD | 21 | 8.9 | 0.2 | 9.8 | 84 | 44 | M |
| H002 | Nephrolithiasis | 21 | 8.0 | 0.2 | 11.7 | 80 | 62 | F |
| H003 | DM, HTN | 31 | NR | NR | 10.7 | 64 | 44 | F |
| H004 | DM, HTN | 43 | NR | NR | 10.3 | 121 | 68 | M |
| H005 | DM, HTN | 24 | NR | NR | 9.8 | 71 | 66 | M |
| H006 | FSGS | 38 | 11.8 | 1.0 | 10.3 | 67 | 27 | M |
| H007 | PCKD | 15 | 4.2 | 1.0 | 10.7 | 63 | 60 | F |
| H008 | DM, HTN | 26 | 9.5 | 2.0 | 10.0 | 76 | 65 | M |
| H009 | DM, HTN | 33 | 14.3 | 2.0 | 10.1 | 74 | 69 | F |
| H010 | PCKD | 28 | 8.9 | 0.6 | 10.8 | 72 | 57 | F |
| H011 | DM, HTN | 34 | 11.8 | 1.4 | 8.9 | 63 | 65 | M |
| H012 | PCKD | 59 | 3.2 | 0.9 | 11.4 | 108 | 40 | M |
| H013 | DM, HTN | 24 | 5.6 | 1.5 | 13.0 | 74 | 60 | F |
Patient ID no. . | Diagnosis . | CrCl, mL/min . | Epo, mU/mL at V2, t0 . | Ret, %, at V2, t0 . | Hb, g/dL at V2, t0 . | Weight, kg . | Age, y . | Gender, F/M . |
|---|---|---|---|---|---|---|---|---|
| H001 | PCKD | 21 | 8.9 | 0.2 | 9.8 | 84 | 44 | M |
| H002 | Nephrolithiasis | 21 | 8.0 | 0.2 | 11.7 | 80 | 62 | F |
| H003 | DM, HTN | 31 | NR | NR | 10.7 | 64 | 44 | F |
| H004 | DM, HTN | 43 | NR | NR | 10.3 | 121 | 68 | M |
| H005 | DM, HTN | 24 | NR | NR | 9.8 | 71 | 66 | M |
| H006 | FSGS | 38 | 11.8 | 1.0 | 10.3 | 67 | 27 | M |
| H007 | PCKD | 15 | 4.2 | 1.0 | 10.7 | 63 | 60 | F |
| H008 | DM, HTN | 26 | 9.5 | 2.0 | 10.0 | 76 | 65 | M |
| H009 | DM, HTN | 33 | 14.3 | 2.0 | 10.1 | 74 | 69 | F |
| H010 | PCKD | 28 | 8.9 | 0.6 | 10.8 | 72 | 57 | F |
| H011 | DM, HTN | 34 | 11.8 | 1.4 | 8.9 | 63 | 65 | M |
| H012 | PCKD | 59 | 3.2 | 0.9 | 11.4 | 108 | 40 | M |
| H013 | DM, HTN | 24 | 5.6 | 1.5 | 13.0 | 74 | 60 | F |
Creatinine clearance (CrCl) was calculated according to Cockcroft-Gault formula.
Ret indicates reticulocyte count; Hb, hemoglobin; F, female; M, male; PCKD, polycystic kidney disease; DM, diabetic nephropathy; HTN, hypertensive nephropathy; NR, not relevant (These patients did not receive an implant, so this result is not relevant.); FSGS, focal segmental glomerulosclerosis and hyalinosis.